HLA in coeliac disease families: A novel test of risk modification by the 'other' haplotype when at least one DQA1*O5-DQB1*02 haplotype is carried

Tissue Antigens

Volumn 60, Issue 2, 2002, Pages 147-154

  Louka, A S ^a   Nilsson, S ^b   Olsson, M ^b   Talseth, B ^a   Lie, B A ^a   Ek, J ^c   Gudjonsdottir A H ^d   Ascher, H ^d   Sollid, L M ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c Buskerud Central Hospital   (Norway)

^d QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Coeliac disease; Gene dosage; Genes; Genotype; MHC class II; Risk assessment

Indexed keywords

HLA DQ ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; HLA ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 02 ANTIGEN; HLA DQB1 ANTIGEN;

ALLELE; ARTICLE; CELIAC DISEASE; FAMILIAL DISEASE; GENE DOSAGE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; HAPLOTYPE; HETEROZYGOSITY; HLA SYSTEM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NARCOLEPSY; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTHERN EUROPE; STATISTICAL ANALYSIS; BIOLOGICAL MODEL; DISEASE PREDISPOSITION; ETHNOLOGY; FAMILY; GENE LINKAGE DISEQUILIBRIUM; GENETICS;

CELIAC DISEASE; DATA INTERPRETATION, STATISTICAL; DISEASE SUSCEPTIBILITY; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA ANTIGENS; HLA-DQ ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MODELS, GENETIC;

EID: 0036702792     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2002.600205.x     Document Type: Article

References (28)

1. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 2001: 120: 636-51.
2. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000: 18: 53-81.
3. Naluai ÅT, Nilsson S, Gudjonsdottir AH et al. Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11. Eur J Hum Genet 2001: 9: 938-44.
4. Petronzelli F, Bonamico M, Ferrante P et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 1997: 61: 307-17.
5. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987: 40: 1-14.
6. Greco L, Corazza G, Babron MC et al. Genome search in celiac disease. Am J Hum Genet 1998: 62: 669-75.
7. Liu J, Juo SH, Holopainen P et al. Genome-wide linkage analysis of celiac disease in Finnish families. Am J Hum Genet 2002: 70: 51-9.
8. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis. Gastroenterology 1993: 105: 910-22.
9. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ a/β heterodimer. J Exp Med 1989: 169: 345-50.
10. Mazzilli MC, Ferrante P, Mariani P et al. A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol 1992: 33: 133-9.
11. Lundin KE, Scott H, Hansen T et al. Gliadin-specific, HLA-DQ (α1*0501, β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993: 178: 187-96.
12. Ploski R, Ek J, Thorsby E, Sollid LM. On the HLA-DQ (α1*0501, β1*0201)-associated susceptibility in celiac disease: A possible gene dosage effect of DQB1*0201. Tissue Antigens 1993: 41: 173-7.
13. Pelin Z, Guilleminault C, Risch N, Grumet FC, Mignot E. HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multi-center Study Group. Tissue Antigens 1998: 51: 96-100.
14. Mignot E, Lin L, Rogers W et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001: 68: 686-99.
15. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993: 52: 506-16.
16. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990: 65: 909-11.
17. Ploski R, Ascher H, Sollid LM. HLA geno-types and the increased incidence of coeliac disease in Sweden. Scand J Gastroenterol 1996: 31: 1092-7.
18. Ronningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E. Distribution of HLA-DRB1-DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1991: 37: 105-11.
19. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage dis-equilibrium and association. Am J Hum Genet 1996: 59: 983-9.
20. Meddeb-Garnaoui A, Zeliszewski D, Mougenot JF et al. Re-evaluation of the relative risk for susceptibility to celiac disease of HLA-DRB1-DQA1-DQB1-DPB1, and -TAP2 alleles in a French population. Hum Immunol 1995: 43: 190-9.
21. Tighe MR, Hall MA, Barbado M, Cardi E, Welsh KI, Ciclitira PJ. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens 1992: 40: 90-7.
22. Mearin ML, Biemond I, Pena AS et al. HLA-DR phenotypes in Spanish coeliac children: Their contribution to the understanding of the genetics of the disease. Gut 1983: 24: 532-7.
23. DeMarchi M, Borelli I, Olivetti E et al. Two HLA-D and DR alleles are associated with coeliac disease. Tissue Antigens 1979: 14: 309-16.
24. Brautbar C, Freier S, Ashkenazi A et al. Histocompatibility determinants in Israeli Jewish patients with coeliac disease: Population and family study. Tissue Antigens 1981: 17: 313-22.
25. McKenna R, Stevens FM, McNicholl B, Scholz S, Albert E, McCarthy CE Family and population studies of HLA and coeliac disease in the West of Ireland. Tissue Antigens 1983: 22: 175-81.
26. Scholz S, Albert E. HLA and diseases: Involvement of more than one HLA-linked determinant of disease susceptibility. Immunol Rev 1983: 70: 77-88.
27. Ellis A, Taylor CJ, Dillon-Remmy M, Woodrow JC, McConnell RB. HLA-DR typing in coeliac disease: Evidence for genetic heterogeneity. Br Med J (Clin Res Ed) 1984: 289: 1571-3.
28. Sachs JA, Awad J, McCloskey D et al. Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis. Gut 1986: 27: 515-20.